As of Dec 13
| -0.01 / -0.57%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.50, with a high estimate of 4.50 and a low estimate of 2.50. The median estimate represents a +102.31% increase from the last price of 1.73.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.